Xtant Medical Holdings XTNT Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 62.9%+4.8pp | 58.2%-2.6pp | 60.8%+5.3pp | 55.4%-3.4pp | |
| Net margin | 3.7%+17.7pp | -14%— | —— | -14.6%-5.9pp | |
| Returns | |||||
| Return on equity | 10.6%+45.5pp | -34.9%— | —— | -26.1%-4.7pp | |
| Return on invested capital | 13.5%+32.9pp | -19.5%+2.7pp | -22.2%+3.3pp | -25.5%-11.8pp | |
| Efficiency | |||||
| Asset turnover | 1.4×+0.2× | 1.3×+0.1× | 1.2×+0.2× | 1×-0.1× | |
| Liquidity | |||||
| Current ratio | 2.7×+0.3× | 2.3×-0.5× | 2.8×-0.4× | 3.2×-0.8× | |
| Leverage | |||||
| Debt-to-equity | 0.4×-0.2× | 0.5×+0.2× | 0.4×0.0× | 0.4×0.0× | |
| Net debt / EBITDA | 0×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $0.34+5.7% | $0.32-20.6% | $0.41+11.5% | $0.36+0.5% | |
| Valuation | |||||
| Market capitalization | $59.05M-32.5% | $61.58M-58.1% | $147.02M+105% | $71.72M+47.5% | |
| Price / earnings | 32.3×— | —— | —— | —— | |
| Price / sales | 0.5×-0.2× | 0.5×-1.1× | 1.6×+0.4× | 1.2×+0.4× | |
| Price / book | 1.2×-0.6× | 1.4×-1.4× | 2.9×+0.8× | 2.1×+0.5× | |
| EV / EBITDA | 5.4×-17.7× | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Xtant Medical Holdings's profit margins?
- Xtant Medical Holdings (XTNT) runs a 62.3% gross margin and a 4.8% operating margin, with a 1.5% net margin.
- Where do Xtant Medical Holdings's ratios come from?
- Every ratio is computed from Xtant Medical Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
